Biochemical Pathways Leading to the Formation of Wyosine Derivatives in tRNA of Archaea by Urbonavičius, Jaunius & Tauraitė, Daiva
biomolecules
Review
Biochemical Pathways Leading to the Formation of
Wyosine Derivatives in tRNA of Archaea
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Abstract: Tricyclic wyosine derivatives are present at position 37 in tRNAPhe of both eukaryotes
and archaea. In eukaryotes, five different enzymes are needed to form a final product, wybutosine
(yW). In archaea, 4-demethylwyosine (imG-14) is an intermediate for the formation of three different
wyosine derivatives, yW-72, imG, and mimG. In this review, current knowledge regarding the archaeal
enzymes involved in this process and their reaction mechanisms are summarized. The experiments
aimed to elucidate missing steps in biosynthesis pathways leading to the formation of wyosine
derivatives are suggested. In addition, the chemical synthesis pathways of archaeal wyosine
nucleosides are discussed, and the scheme for the formation of yW-86 and yW-72 is proposed. Recent
data demonstrating that wyosine derivatives are present in the other tRNA species than those specific
for phenylalanine are discussed.
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1. Introduction
All transfer RNAs contain posttranscriptional modifications that are essential for the maintenance
of the structure and proper functioning. Some of these modifications are chemically simple, whereas the
other ones are complex, requiring several steps for biochemical synthesis [1]. One group of such
modifications are the wyosine derivatives, tricyclic imidazopurines derived from the guanine, and found
at position 37 of tRNAPhe isolated from eukaryotes and Archaea [2]. The first report on such derivatives
was published by RajBhandary and Chang more than 50 years ago, where the presence of a fluorescent
derivative called Y-base was described in yeast Saccharomyces cerevisiae [3]. Wyosine derivatives
were shown to be involved in codon–anticodon interactions [4], thereby preventing ribosomal -1
frameshifting [5,6].
The metabolic pathway leading to wybutosine (yW) in the cytoplasmic tRNAPhe has
been established first in yeast Saccharomyces cerevisiae using comparative genomics, knockout,
and complementation [7]. This pathway includes five sequential reactions, each catalyzed by a
distinct enzyme and starts with the formation of the N1-methylguanosine (m1G). Only the first
reaction occurs in the nucleus [8]. In the fungi, Torulopsis utilis, wyosine (imG) is formed instead
of wybutosine [9]. Similarly, the imG is found in mitochondria of a protist Trypanosoma brucei [10].
In contrast, several eukaryotes (Drosophila melanogaster, Bombyx mori, Tinca tinca) possess only m1G
since no genes of the wyosine biosynthesis pathway are found in these organisms [11–13].
Several reports provide links between the synthesis of wyosine derivatives in human cells and
cancer. It was observed that tRNAPhe isolated from rat and mouse tumors did not contain a fully
modified yW base that was present in normal tissues [14]. In addition, it was demonstrated that the
human TYW2 gene is overexpressed in cancer [15]. Later, it was established that the function of hTYW2
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is similar to the one of yeast counterpart [16] and that the loss of this protein induces -1 frameshifting
in colon cancer [17].
In Archaea, several different wyosine derivatives are found [18]. Still, in euryarchaeon Haloferax volcanii,
no wyosine derivatives, but only m1G is present in tRNAPhe [19]. In many other Euryarchaeota,
7-aminocarboxypropyl-4-demethylwyosine (yW-86) and 7-aminocarboxypropyl-wyosine (yW-72)
that were previously considered to be the intermediates of the eukaryotic pathway are found
([18,20], Scheme 1). For simplicity, trivial names are used when describing the wyosine derivatives.
Compared to eukaryotes, two additional wyosine derivatives have been identified in Archaea:
isowyosine (imG2) and 7-methylwyosine (mimG) ([20,21], Scheme 1). Moreover, in several archaeal
species, a mixture of different wyosine derivatives has often been observed [18]. Recently, it was
reported that five additional tRNAs isolated from Methanocaldococcus jannaschii contain either
4-demethylwyosine (imG-14) or wyosine (imG) at position 37 [22]. Moreover, the sequencing of
tRNATrp isolated from Thermococcus kodakarensis demonstrated the presence of 7-methylwyosine
at position 37 [23]. These surprising findings await further confirmation and the corresponding
modification enzymes—biochemical and structural characterization.
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2. Enzymatic Formation of 1-Methylguanosine, Intermediate in the Pathway Leading to the
Formation of Wyosine Derivatives
Biosynthesis of wyosine derivatives in Archaea starts with methylation of guanosine by
methyltransferases belonging to the Trm5 family of enzymes to produce 1-methylguanosine (m1G)
that is present not only in tRNAPhe but also in several other tRNA species (Scheme 1, see also [1]).
The absence of m1G in different tRNA species induces the +1 translational frameshifting [24,25].
Interestingly, the formation of m1G in bacteria is catalyzed by the TrmD family of enzymes that are
evolutionarily distinct from the Trm5 one, which in addition to Archaea, is also present in eukaryotes.
These two families of enzymes have different structures and use different approaches for substrate
recognition. TrmD and Trm5 enzymes have been compared in a recent review by Goto-Ito et al. [26].
TrmD family will not be further discussed here; instead, the focus will be made on the Trm5 family
of Archaea.
Previously, it was assumed that Trm5 enzymes in Archaea consist of three subfamilies,
Trm5a/b/c [18]. Our recent theoretical and experimental investigations [2,27] demonstrate that the Trm5a
subfamily of enzymes belongs to wyosine biosynthesis pathways even though the Trm5a = Taw22 also
catalyzes the formation of m1G (Scheme 1). Trm5a subfamily will be described below in the section
that concerns the biosynthesis of isowyosine (imG2). Trm5b subfamily of enzymes is found in the
Euryarchaeota group of Archaea, whereas Trm5c exists in Sulfolobales and Desulfurolcoccales orders
of Crenoarchaeota [2]. A small conserved D1 domain is always present in both Trm5b and Trm5c,
whereas it is absent in a majority of aTrm5a [18], which is a major structural difference between Trm5b/c
and Trm5a; however, the differences between Trm5b and Trm5c families of enzymes are not that
evident. It was described by J.Bujnicki that Trm5 proteins have a Rossman fold at C-termini for catalytic
function, and also the NPPY motif at the fourth β-strand for positioning of N-atom of G37 substrate [28].
The crystal structures of Trm5b proteins were first determined for Methanococcus jannaschii (MjTrm5b)
either without (Protein Data Bank (PDB) 2YX1) or with tRNA substrates (PDBs 2ZZM and 2ZZN) [29,30]
and then for Pyrococcus abyssi (PaTrm5b) apo-enzyme (PDB 5YAC) [31]. In the latter work, it was
demonstrated that the truncation of the D1 domain of PaTrm5b leads both to reduced binding to tRNA
and enzymatic activity. To our knowledge, no crystal structures of Trm5c are available. The available
structures of Trm5a enzymes and thereby structure-function relationships will be discussed in a section
that concerns the formation of imG2 wyosine derivative.
3. Enzymatic Biosynthesis of Wyosine Derivatives
The other biosynthesis steps are specific for wyosine derivatives. The enzymes that catalyze
such reactions in Archaea are named Taw for tRNA archaeal wyosine derivatives. Although these
enzymes are often also named Tyw in the literature, it was suggested that such nomenclature should
be used only for the yeast (or other eukaryotes), but not for archaeal enzymes, to make a distinction
between the proteins present in the corresponding domain of life [18]. In this section, the biosynthesis
of different intermediates and final products is described.
3.1. Formation of imG-14 by Taw1 Enzyme
Biosynthesis of wyosine derivatives in Archaea starts with the formation of the imidazo-purine
ring yielding the 4-demethylwyosine (imG-14) that is catalyzed by the Taw1 enzyme. For the formation
of different wyosine derivatives, S-adenosine-l-methionine (SAM) is used as a donor of the methyl
or 3-amino-3-carboxypropyl (“acp”) groups. However, Taw1 is unique since it is a member of the
radical SAM superfamily, which was identified based on a conserved CxxxCxxC motif [32] that is
used for binding of [4Fe–4S] cluster. Here, SAM is used to activate the substrate rather than the
chemical group donor. In Tyw1 of S. cerevisiae, a flavodoxin-like domain that binds an FMN cofactor is
found [7]. In that work, it was demonstrated that conservative cysteines that bind [4Fe–4S] cluster
are required for the formation of imG-14. To our knowledge, no data on structural and biochemical
characterization of this or other eukaryotic proteins is available except for the unpublished structure of
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putative Schizosaccharomyces japonicus Tyw1 flavodoxin-like domain (6PUQ and 6PUP in Protein Data
Bank); further characterization of this family of enzymes was done in Archaea. It was demonstrated
that the formation of the imidazole ring from m1G requires two new carbon atoms, originating from
the pyruvate, whose C2 and C3 atoms are incorporated into the imidazole ring [33,34]. Please note that
the formation of the third ring changes the way the atoms are numbered (Scheme 1). Further structural,
mechanistic, and spectroscopic studies on Taw1 proteins isolated either from Pyrococcus horikoschii,
P.abissi, or M.jannaschii, revealed that they contain two [4Fe–4S] clusters [35–38] (Figure 1), and allowed
to propose an enzymatic mechanism of the 3rd ring formation reaction, where the reductively cleaved
SAM provides dAdo to initiate catalysis by abstracting a hydrogen atom from m1G, whereas second
(so-called auxiliary) cluster is used for the activation of pyruvate by forming a Schiff base and
decarboxylation [39,40], summarized in Scheme 2. More information about Taw1 and the other radical
SAM enzymes may be found in a recent volume of Methods in Enzymology issue “Radical SAM
enzymes” [41].
Biomolecules 2020, 10, x 4 of 16 
unpublished structure of putative Schizosaccharomyces japonicus Tyw1 flavodoxin-like domain (6PUQ 
and 6PUP in Protein Data Bank); further characterization of this family of enzy es was done in 
Archae . It as demonstrated that the formation of the imidazole ring from m1G requires two new 
carbon atoms, originating from th  pyruv te, whose C2 and C3 atoms are incorporated into the 
imidazole ring [33,34]. Please note that the formation of the third ring c anges the way the atoms are 
numbered (Scheme 1). Further structural, mechanistic, and spectroscopic studies on Taw1 proteins 
isolated either from Pyrococcus horikoschii, P.abissi, or M.jannaschii, revealed that they contain two 
[4Fe-4S] clusters [35–38] (Figure 1), and allowed to propose an enzymatic mechanism of the 3rd ring 
formation reaction, where the reductively cleaved SAM provides dAdo to initiate catalysis by 
abstracting a hydrogen atom from m1G, whereas second (so-called auxiliary) cluster is used for the 
activation of pyruvate by forming a Schiff base and decarboxylation [39,40], summarized in Scheme 
2. More information about Taw1 and the other radical SAM enzymes may be found in a recent 
volume of Methods in Enzymology issue “Radical SAM enzymes” [41]. 
 
Figure 1. Crystal structures of Taw1. (A) Apo structure of P. horikoshii (PDB 2XY0). (B) Apo structure 
of M.jannaschii (PDB 2Z2U). (C) M.jannaschii structure with lysine-pyruvate adduct (PDB 6DJT). K41 
adduct with pyruvate (purple sticks) and the [4Fe-4S] clusters (yellow-brown spheres) are depicted 
and labeled. Figures 1–3 were made using PyMOL (https://pymol.org/2/). 
Figure 1. Crystal structures of Taw1. (A) Apo structure of P. horikoshii (PDB 2XY0). (B) Apo structure
of M. jannaschii (PDB 2Z2U). (C) M. jannaschii structure with lysine-pyruvate adduct (PDB 6DJT).
K41 adduct with pyruvate (purple sticks) and the [4Fe–4S] clusters (yellow-brown spheres) are depicted
and labeled. Figures 1–3 were made using PyMOL (https://pymol.org/2/).Biomolecules 2020, 10, x 6 of 16 
 
Figure 2. Crystal structures of Taw2, Trm5a=Taw22 and Trm5b. (A) Structure of P. horikoshii Taw2 in 
complex with S-adenosine-L-methionine (SAM) (PDB 3A25). SAM is depicted as rainbow sticks. 
Critical G199 residue (corresponding to N265 in M. jannaschii Trm5b) is depicted as an orange sphere. 
(B) Structure of P.abyssi Trm5a=Taw22 in complex with MTA (5′-methylthioadenosine) and tRNAPhe 
(PDB 5WT3). D1 domain of Trm5a is shown in red, and the rest of the protein—in blue. Critical P260 
residue (corresponding to N265 in M. jannaschii Trm5b) is depicted as an orange sphere. Transfer 
RNA is shown in magenta, except for G37 that is shown in green. MTA is depicted as the rainbow 
sticks. (C) M. jannaschii Trm5b structure in complex with SAM and tRNALeu (PDB 2ZZM). D1 domain 
of Trm5b is shown in red, and the rest of protein—in blue. Critical N265 residue is depicted as an 
orange sphere. Transfer RNA is shown in magenta, except for G37 that is shown in green. SAM is 
depicted as the rainbow sticks. 
3.3. Formation of imG2 by Taw21/Taw22 (aTrm5) Enzymes 
Isowyosine (imG2), together with 7-methylwyosine (mimG), are archaea-unique wyosine 
derivatives that are present in Thermococalles and several Crenarchaeota ([2,18] and references 
therein). It has been suggested that imG2 is the likely intermediate of mimG biosynthesis ([2,47], 
Figure 1). The occurrence of imG2 in different Archaea strictly correlates with the presence of archaeal 
Trm5a ([2] and references therein). As described above, the Archaeal Trm5a family is characterized 
by the absence (in many cases) of the D1 domain that is present in the Trm5b/c family of 
methyltransferases, responsible for the conversion of guanosine into 1-methylguanosine [27]. In some 
Archaea, like Thermoproteales order of Crenarchaeota, and nanoarchaeon Nanoarchaeum equitans, 
Trm5a is the only enzyme of the Trm5 family present, suggesting that it catalyzes the formation of 
not only imG2 but also of m1G. Indeed, it was demonstrated that recombinant Trm5a of N. equitans 
catalyzes the formation of both m1G and imG2. Based on these findings, we proposed to rename such 
dual-specificity Trm5a proteins into Taw22 ([2,27] Scheme 1). In addition to the formation of m1G in 
tRNAPhe, this enzyme is probably responsible for the formation of such modification in other tRNA 
species of N. equitans. A different situation exists in some Crenarchaeota, like Desulforococcales and 
Sulfolobales, where Trm5c is present alongside Trm5a and likely corresponds for the formation of 
m1G [2], whereas Trm5a is responsible for the formation of imG2. Indeed, we have demonstrated that 
Trm5a of Sulfolobus solfataricus catalyzes the formation of imG2, but not of m1G [27]. Based on these 
results, it was proposed to rename the monofunctional Trm5a enzymes into Taw21. 
The situation is even more complicated in the Thermococcales order of Euryarchaeota. Here, 
Trm5b is present alongside the Trm5a. We have demonstrated that the Trm5a enzyme of P. abyssi 
catalyzes the formation of both imG2 and m1G in tRNAPhe, but not in tRNAAsp [18,27]. We conclude 
that in this organism, Taw22 acts on tRNAPhe, whereas Trm5b is responsible for the methylation of 
G37 in other m1G-containing tRNAs. 
Several crystal structures of PaTrm5a=Taw22 with different cofactors and/or tRNA substrates 
were obtained (PDB 5HJJ, 5HJI, 5HJK, 5HJM, 5WT1, 5WT3) [48,49]. Structures of PaTrm5a without 
the tRNA substrate demonstrated an extended conformation (“open” state) compared to the well-
folded MjTrm5b. Fluorescence resonance energy transfer (FRET) experiments demonstrated that 
Figure 2. Crystal structures of Taw2, Tr 5a = Taw22 and Trm5b. (A) Structure of P. horikoshii Taw2
in co plex ith S-adenosine-L-methionine (SAM) (PDB 3A25). SAM is depicted as rainbow sticks.
Critical G199 residue (corresponding to i . jannaschii Trm5b) is depicted s an orange sphere.
(B) Struct re of P. abyssi Trm5a=Taw2 in complex it ′- ethylthioadenosine) and tRNAPhe
(PDB 5WT3). D1 domain of Trm5a is shown i rest of the protein—in blue. Critical P260
residue (corresponding to N265 in M. jannaschii Trm5b) is depicted as n orange sphere. Transfer RNA
is shown in magenta, except for G37 that is shown in green. MTA is depict d as the rainbow sticks.
(C) M. jannaschii Trm5b structure in complex with SAM and tRNALeu (PDB 2Z M). D1 ai of
Trm5b is shown in red, and the rest of protein—in blue. Critical N265 residue is depicted as an orange
sphere. Transfer RNA is shown in magenta, except for G37 that is shown in green. SAM is depicted as
the rainbow sticks.
Biomolecules 2020, 10, 1627 5 of 15
Biomolecules 2020, 10, x 8 of 16 
jannaschii and Methanothermococcus litotrophus [2]. The enzymatic activity of these enzymes may be 
elucidated by incubating them with tRNA isolated from yeast tyw2 mutant (possessing imG-14) and 
monitoring the formation of the imG-14 product by HPLC/MS or TLC as performed previously for 
the other Tyw/Taw enzymes [7,18,27]. 
In several Crenarchaeota like Sulfolobus solfataricus, also in Thermoproteales Thermoproteus 
neutropylus, Pyrobaculum calidifontis, and Pyrobaculum islandicum, single Taw3 enzymes likely 
methylate imG2 into mimG because these two wyosine derivatives (and sometimes the imG-14 
intermediate) are found in tRNA, whereas imG and yW-72 are not [2]. We propose to name these 
enzymes Taw3c. In recent work, the crystal structure of putativeTaw3c protein from S. solfataricus 
was solved and revealed a novel α/β fold, which constitutes a new class of methyltransferases 
composed of SHS2, RAGNYA fold domains, and an N-terminal extension (PDB 1TLJ, [50], Figure 3). 
 
Figure 3. Crystal structure of S. solfataricus Taw3 protein (PDB 1TLJ). N-terminal extension, RAGNYA 
and SHS2 fold domains are displayed in red, blue, and yellow, respectively. 
Interestingly, total tRNA isolated from S. cerevisiae tyw3 mutant and possessing yW-86 was not 
a substrate for SsTaw3c enzyme, clearly distinguishing it from yeast Tyw3 or Pyrococcus Taw3a 
proteins. Transfer RNA isolated from S. cerevisiae tyw2 mutant and possessing imG-14 was also not a 
substrate for S. solfataricus Taw3c, clearly distinguishing it from Taw3b. No homologous tRNA 
substrate isolated from S. solfataricus tyw3 mutant (possessing imG2) was used. Still, the development 
of the Sulfolobus genetics tools now allows the creation of such mutants in three closely related 
archaea, S. sulfotaricus, S. acidocaldarius, and S. islandicus [51–53], which would allow establishing the 
enzymatic activity of Taw3c. 
In the aforementioned work [50], the structure of SsTaw3c was compared with the other three 
Taw3 structures deposited into PDB: Archaeoglobus fulgidus (PDB 2QG3), Pyrococcus horikoshii (PDB 
2IT2), and Aeropyrum pernix (PDB 2DVK)). It was shown that all three structures share the same 
domain architecture and overall fold as SsTaw3. However, it is not clear whether these Taw3 enzymes 
belong to the Taw3c subgroup. Two copies of Taw3 enzymes are present in P. horikoshii [18], similarly 
as in P. abyssi and P. furiosus; the enzymatic activity of the copy with solved structure (PH1069) is 
unknown. In A. fulgidus, Trm5a, Taw1, Taw2, and one copy of Taw3 is present [18], but no mimG is 
found in tRNA [54]. Therefore, it is possible that AF2059 (AfTaw3) protein is responsible for the 
formation of either yW-72 (Taw3a activity) or imG (Taw3b activity), or both. Only APE0816 
Figure 3. Crystal structure of S. solfataricus Taw3 protein (PDB 1TLJ). N-terminal extension, RAGNYA
and SHS2 fold domains are displayed in red, blue, and yellow, respectively.Biomolec les 2020, 10, x 5 of 16 
 
Scheme 2. The proposed enzymatic mechanism for Taw1. 
3.2. Formation of yW-86 by the Taw2 enzyme 
4-Demethylwyosine (imG-14) serves as a core compound for further modifications leading to 
the formation of either 7-aminocarboxypropyl-demethylwyosine (yW-86), wyosine (imG), or 
isowyosine (imG2). Taw2 enzyme belongs to the same cluster of orthologous groups 
(COG2520/PACE 25) as Trm5a/b/c methyltransferases [42,43]. These paralogs use the same SAM 
cofactor but transfer either the methyl group onto the guanosine or 3-amino-3-carboxypropyl (“acp“) 
groups onto the imG-14. The acp group containing tRNA modifications are known for bacteria and 
eukaryotes (acp3U20 and acp3U47); recently, the gene responsible for the formation of acp3U47 was 
identified in Escherichia coli [44,45]. Formation of yW-86 from imG-14 was demonstrated in vitro for 
the recombinant M. jannaschii and P. horikoshii Taw2 enzymes using tRNA isolated from yeast tyw2 
mutant and SAM cofactor [46]. In the same work, determination of the crystal structure (Figure 2A) 
and mutagenesis of the aforementioned enzymes revealed that juxtaposition and orientation of imG-
14 (including the critical residue G199) and the absence of D1 domain are likely responsible for the 
transfer of the “acp“, but not the methyl group at the C7 position of the target base. 
Scheme 2. The proposed enzymatic mechanism for Taw1.
Biomolecules 2020, 10, 1627 6 of 15
3.2. Formation of yW-86 by the Taw2 Enzyme
4-Demethylwyosine (imG-14) serves as a core compound for further modifications leading to the
formation of either 7-aminocarboxypropyl-demethylwyosine (yW-86), wyosine (imG), or isowyosine
(imG2). Taw2 enzyme belongs to the same cluster of orthologous groups (COG2520/PACE 25) as
Trm5a/b/c methyltransferases [42,43]. These paralogs use the same SAM cofactor but transfer either the
methyl group onto the guanosine or 3-amino-3-carboxypropyl (“acp”) groups onto the imG-14. The acp
group containing tRNA modifications are known for bacteria and eukaryotes (acp3U20 and acp3U47);
recently, the gene responsible for the formation of acp3U47 was identified in Escherichia coli [44,45].
Formation of yW-86 from imG-14 was demonstrated in vitro for the recombinant M. jannaschii and
P. horikoshii Taw2 enzymes using tRNA isolated from yeast tyw2 mutant and SAM cofactor [46]. In the
same work, determination of the crystal structure (Figure 2A) and mutagenesis of the aforementioned
enzymes revealed that juxtaposition and orientation of imG-14 (including the critical residue G199)
and the absence of D1 domain are likely responsible for the transfer of the “acp”, but not the methyl
group at the C7 position of the target base.
3.3. Formation of imG2 by Taw21/Taw22 (aTrm5) Enzymes
Isowyosine (imG2), together with 7-methylwyosine (mimG), are archaea-unique wyosine
derivatives that are present in Thermococalles and several Crenarchaeota ([2,18] and references
therein). It has been suggested that imG2 is the likely intermediate of mimG biosynthesis ([2,47],
Figure 1). The occurrence of imG2 in different Archaea strictly correlates with the presence of
archaeal Trm5a ([2] and references therein). As described above, the Archaeal Trm5a family is
characterized by the absence (in many cases) of the D1 domain that is present in the Trm5b/c family of
methyltransferases, responsible for the conversion of guanosine into 1-methylguanosine [27]. In some
Archaea, like Thermoproteales order of Crenarchaeota, and nanoarchaeon Nanoarchaeum equitans,
Trm5a is the only enzyme of the Trm5 family present, suggesting that it catalyzes the formation of
not only imG2 but also of m1G. Indeed, it was demonstrated that recombinant Trm5a of N. equitans
catalyzes the formation of both m1G and imG2. Based on these findings, we proposed to rename such
dual-specificity Trm5a proteins into Taw22 ([2,27] Scheme 1). In addition to the formation of m1G in
tRNAPhe, this enzyme is probably responsible for the formation of such modification in other tRNA
species of N. equitans. A different situation exists in some Crenarchaeota, like Desulforococcales and
Sulfolobales, where Trm5c is present alongside Trm5a and likely corresponds for the formation of
m1G [2], whereas Trm5a is responsible for the formation of imG2. Indeed, we have demonstrated that
Trm5a of Sulfolobus solfataricus catalyzes the formation of imG2, but not of m1G [27]. Based on these
results, it was proposed to rename the monofunctional Trm5a enzymes into Taw21.
The situation is even more complicated in the Thermococcales order of Euryarchaeota. Here,
Trm5b is present alongside the Trm5a. We have demonstrated that the Trm5a enzyme of P. abyssi
catalyzes the formation of both imG2 and m1G in tRNAPhe, but not in tRNAAsp [18,27]. We conclude
that in this organism, Taw22 acts on tRNAPhe, whereas Trm5b is responsible for the methylation of G37
in other m1G-containing tRNAs.
Several crystal structures of PaTrm5a=Taw22 with different cofactors and/or tRNA substrates were
obtained (PDB 5HJJ, 5HJI, 5HJK, 5HJM, 5WT1, 5WT3) [48,49]. Structures of PaTrm5a without the tRNA
substrate demonstrated an extended conformation (“open” state) compared to the well-folded MjTrm5b.
Fluorescence resonance energy transfer (FRET) experiments demonstrated that such conformation
is also a natural one in solution [48]. Subsequent SAXS (small-angle X-ray scattering) experiments
confirmed the FRET data [49]. The co-crystal structures of PaTrm5a with tRNAPhe substrate and
S-adenosyl-L-homocysteine (SAH) or 5′-methylthioadenosine (MTA, a degradation product of SAM)
let to propose the reaction mechanism of this enzyme. It was demonstrated that the orientation of the
tRNA substrate and SAM cofactor towards either Trm5a or Trm5b is similar. The capability of Trm5a
to catalyze the formation of imG2 in addition to m1G probably arises due to substrate recognition
motif 260PTPK263 that is different from the conserved NPPY motif in other Trm5s. The side chain of
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Asn265 of MjTrm5b causes the steric clashes with the tricyclic ring produced by Taw1. In contrast,
the PaTrm5a contains a proline instead of asparagine in the PTPK motif that allows the accommodation
of the imG-14 substrate [49] (Figure 2B,C).
3.4. The Enzymatic Activity of Taw3 Proteins
The enzymes of the Taw3 family are the SAM-dependent methyltransferases that all belong to
the COG1590/PACE24 group of proteins [42,43]. These enzymes catalyze three distinct reactions:
formation of yW-72 from yW-86, imG from imG-14, and mimG from imG2. We propose to name such
enzymatic activities Taw3a, Taw3b, and Taw3c, respectively (Scheme 1). In yeast, methylation of yW-86
to yield yW-72 is catalyzed by the Tyw3 enzyme. Orthologs of this enzyme are present in Archaea,
and their enzymatic specificity must correlate with the presence of wyosine derivatives in different
species. These relationships are discussed below and, for simplicity, are summarized in Table 1.
Table 1. Correlation between the presence of wyosine derivatives in certain archaeal species, number
of taw3 genes, and predicted Taw3 enzymatic activities.

















A. fulgidus ? (no mimG) 1 a, b, or a/b





* Only those wyosine derivatives that are produced by the action of Taw3 enzymes are presented.
For example, two copies of Taw3 are found in P. furiosus and P. abyssi [18]. Such two enzymes
must catalyze the formation of yW-72, imG, and mimG present in these organisms, thereby providing
Taw3a/b/c activities. The preliminary results (Urbonavičius, unpublished) demonstrated that one
of two Taw3 proteins from P. abyssi incorporates the radioactive methyl groups into tRNA isolated
from S. cerevisiae tyw2 (possessing the imG-14 substrate) and tyw3 (possessing the yW-86 substrate)
mutants, and M. acetovorans (possessing imG-14, imG2, and yW-86 substrates), suggesting that it has
at least Taw3a/b and possibly Taw3a/b/c activities. In contrast, another Taw3 enzyme incorporates
the radioactive methyl groups only into tRNA isolated from S.cerevisiae tyw2 mutant (possessing the
imG-14 substrate, Taw3b activity). However, more experiments are needed to confirm these results.
For several Archaea, it is evident that Taw3 enzymes methylate imG-14 to form imG (Taw3b
activity) since they contain only one copy of the corresponding gene in their genomes, and neither
yW-72 nor imG2 is found in these organisms. This applies to several Methanococcales such as
M. jannaschii and Methanothermococcus litotrophus [2]. The enzymatic activity of these enzymes may be
elucidated by incubating them with tRNA isolated from yeast tyw2 mutant (possessing imG-14) and
monitoring the formation of the imG-14 product by HPLC/MS or TLC as performed previously for the
other Tyw/Taw enzymes [7,18,27].
In several Crenarchaeota like Sulfolobus solfataricus, also in Thermoproteales Thermoproteus neutropylus,
Pyrobaculum calidifontis, and Pyrobaculum islandicum, single Taw3 enzymes likely methylate imG2 into
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mimG because these two wyosine derivatives (and sometimes the imG-14 intermediate) are found in
tRNA, whereas imG and yW-72 are not [2]. We propose to name these enzymes Taw3c. In recent work,
the crystal structure of putativeTaw3c protein from S. solfataricus was solved and revealed a novel α/β
fold, which constitutes a new class of methyltransferases composed of SHS2, RAGNYA fold domains,
and an N-terminal extension (PDB 1TLJ, [50], Figure 3).
Interestingly, total tRNA isolated from S. cerevisiae tyw3 mutant and possessing yW-86 was not a
substrate for SsTaw3c enzyme, clearly distinguishing it from yeast Tyw3 or Pyrococcus Taw3a proteins.
Transfer RNA isolated from S. cerevisiae tyw2 mutant and possessing imG-14 was also not a substrate
for S. solfataricus Taw3c, clearly distinguishing it from Taw3b. No homologous tRNA substrate isolated
from S. solfataricus tyw3 mutant (possessing imG2) was used. Still, the development of the Sulfolobus
genetics tools now allows the creation of such mutants in three closely related archaea, S. sulfotaricus,
S. acidocaldarius, and S. islandicus [51–53], which would allow establishing the enzymatic activity
of Taw3c.
In the aforementioned work [50], the structure of SsTaw3c was compared with the other three
Taw3 structures deposited into PDB: Archaeoglobus fulgidus (PDB 2QG3), Pyrococcus horikoshii (PDB
2IT2), and Aeropyrum pernix (PDB 2DVK)). It was shown that all three structures share the same domain
architecture and overall fold as SsTaw3. However, it is not clear whether these Taw3 enzymes belong
to the Taw3c subgroup. Two copies of Taw3 enzymes are present in P. horikoshii [18], similarly as in
P. abyssi and P. furiosus; the enzymatic activity of the copy with solved structure (PH1069) is unknown.
In A. fulgidus, Trm5a, Taw1, Taw2, and one copy of Taw3 is present [18], but no mimG is found in
tRNA [54]. Therefore, it is possible that AF2059 (AfTaw3) protein is responsible for the formation of
either yW-72 (Taw3a activity) or imG (Taw3b activity), or both. Only APE0816 (ApTaw3) protein is
likely to have a Taw3c activity, based on the similar distribution of Taw proteins and phylogenetic
closeness to Sulfolobus [18].
Interestingly, Pyrolobus fumarii contains two copies of Taw3, and both imG and mimG [2].
Therefore, it is likely that one of these copies is responsible for the formation of imG (Taw3b activity),
whereas another one—for the formation of mimG (Taw3c activity). In Steteria hydrogenophyla and
Staphylothermus marinus, a single copy of Taw3 seems to be responsible for the formation of both
imG and mimG, therefore possessing Taw3b/c activities [2,18,55]. However, these predictions await
experimental confirmation.
4. Chemical Synthesis of Wyosine Nucleosides
Determination of the identity of naturally occurring compounds requires their isolation and
comparison of structure with corresponding chemically synthesized derivatives. Usually, the wyosine
derivatives are analyzed by isolation of tRNA, digestion of it to the nucleotides and then nucleosides,
and performing the HPLC/MS analysis [7,27]. In this part, the chemical synthesis of wyosine nucleosides
that are present in Archaea will be described. The rationale for the chemical synthesis of nucleosides
differs from the biochemical one. Synthesis schemes are similar for the nucleosides that differ only by
the presence of one methyl group at certain positions; therefore, they will be described pairwise.
4.1. Synthesis of imG-14 and imG2
Synthesis of both compounds is performed by the formation of imidazo-ring from guanosine to
form N1-N2 two-carbon bridge; the first report of imG-14 synthesis being published by Kasai and
coworkers in 1976 [21,27,56,57]. To obtain demethylwyosine (imG-14), guanosine is reacted with
chloro- or bromoacetone after treatment of guanosine with sodium hydride (Scheme 3).
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nucleosides by intramolecular cyclization reaction.
Similarly, isowyosine (imG2) is obtained from guanosine using either 3-bromo-2-butanone or
3-chloro-2-butanone. This one-ste reaction does not require the protection of hydroxy groups of the
guanosi e a d leads to the strongly fluorescent tri ucleosides at the yield of 4 –60%.
4.2. Synthesis of imG and mimG
The wyosine (imG) and methylwyosine (mimG) may be obtained similarly as imG-14 and imG2
by ring closure reaction, starting from 3-methylguanosine (m3G) [58,59]. However, 3-methylguanosine
is not commercially available and cannot be obtained by direct methylation of the guanosine.
The synthesis of m3G is a laborious multistep procedure that requires the usage of some harmful
reagents, such as cyanogen bromide, Vielsmeier reagent (CH3)2 N+=CHCl−, long reaction times (e.g.,
240 h methylation with methyl iodide), and also repeating the protection/deprotection steps of hydroxy
groups [60,61]. Scheme 4 depicts the 10-step synthesis of imG or mimG starting from the inosine (I)
via key intermediate 3-methylguanosine, following by ring closure reaction with overall yield only up
to 1% (Tauraitė, Tunpublished).
The alternative synthesis route for the imG and mimG starts from the tricyclic imG or mimG
compounds by the direct methylation of N4-position with diethylzinc ZnEt2 and iodomethane
CH2I2 [62,63]. In contrast to guanine, the tricyclic heterocyclic base can be methylated directly
and regioselectively at N4-position using an organozinc reagent, produced in situ by the reaction
of iodomethane with diethylzinc in dimethoxyethane (glyme). This synthesis route is shorter,
more efficient, and leads to an overall yield of 10–15%. It starts from the guanosine that is first
converted to imG-14 or imG2 derivatives (Scheme 3) that are subsequently methylated, producing
imG or mimG (Scheme 5).
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4.3. Synthesis of yW-86 and yW-72
As was mentioned above, chemically synthesized wyosine derivatives are necessary for the
determination of the identity of modified nucleosides isolated from tRNA. To our knowledge,
7-aminocarboxypropyl-demethylwyosine (yW-86) and 7-amino-carboxypropyl-wyosine (yW-72) have
never been chemically synthesized. Their presence in tRNA is inferred from the HPLC/MS analysis
data without comparison with chemically synthesized derivatives.
We propose a synthesis scheme that is based on the previous work of Itaya and Carell groups [63–65].
Synthesis of yW-86 or y -72 starts from either imG-14 or imG. One of the possible synthesis routes is
via an iodinated key intermediate, which is obtained by the introduction of iodine at position C7 of
either compound. The next step is the Heck coupling between 7-iodo-tricyclic nucleosides and the
vinyl glycine. Following catalytic h drogenatio with palladium on carbon and the deprotection of the
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hydroxy groups, the desired hypermodified wyosine derivatives yW-86 and yW-72 may be obtained
(Scheme 6).
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5. Conclusions and Future Directions
In this review, we summarized the current knowledge regarding one of the most complex
biosynthetic pathways in archaeal tRNA—biosynthesis of the wyosine derivatives. Recent biochemical
and structural work elucidated the enzymatic mechanisms leading to the formation of the imidazopurine
ring from 1-methylguanosine catalyzed by Taw1 enzyme that uses 5′-deoxyadenosine radical to initiate
the 3rd ring cloture. It was also established that further modifications are catalyzed by distinct enzymes
belong to the COG2520 family (the same that participates in the methylation of guanosine) that
use the SAM cofactor to provide either the methyl- or 3-amino-3-carboxypropyl groups to further
modify the imidazopurine ring. Whereas Taw2 enzymes catalyze the formation of yW-86, either the
monofunctional (Trm5a = Taw21) or bifunctional (Trm5a = Taw22) enzymes add the methyl group onto
imG-14 to form the imG2. Structural and biochemical characterization of Taw21 proteins is needed to
understand why their enzymatic activity differs from those of Taw22 and Trm5b/c.
We also noted that the knowledge regarding the last steps of the formation of the wyosine
derivatives in Archaea is scarce since no enzymatic activity of the Taw3 family of proteins that are
homologs of S. cerevisiae Tyw3 and belong to the COG1590 family was demonstrated. We proposed
that this family of enzymes possess at least three distinct enzymatic activities. To elucidate such
enzymatic activities, different wyosine nucleosides are required. Two of those, yW-86 and yW-72, have
not been chemically synthesized previously. Here, we propose the scheme for the total synthesis of
such nucleosides. By this, we provide the synthesis routes for all archaea-specific wyosine derivatives.
The recent development of direct tRNA sequencing methods led to the determination of wyosine
derivatives in several tRNA species that are not specific for phenylalanine. Therefore, the currently
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accepted paradigm that wyosine derivatives are present only in tRNAPhe may be reconsidered in the
near future, and previously obtained data regarding the activities of the enzymes involved in the
formation of wyosine derivatives may be revised.
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